Sort   by:  
 Page size 
UnknownTransdisciplinary Bioblitz: Rapid biotic and abiotic inventory allows studying environmental changes over 60 years at the Biological Field Station of Paimpont (Brittany, France) and opens new interdisciplinary research opportunities.
Not available
S-EPMC7125239 | biostudies-literature
UnknownReal-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura.
Not available
S-EPMC7362370 | biostudies-literature
UnknownADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP.
Not available
S-EPMC7362349 | biostudies-literature
UnknownApolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774 | biostudies-literature
UnknownAdjunctive Azithromycin Prophylaxis for Cesarean Delivery.
Not available
S-EPMC5131636 | biostudies-literature
UnknownSafety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957 | biostudies-literature
UnknownEffects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial.
Not available
S-EPMC9647563 | biostudies-literature
UnknownVanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.
Not available
S-EPMC12184100 | biostudies-literature
UnknownPatient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials.
Not available
S-EPMC9975919 | biostudies-literature
UnknownInterleukin-2 therapy in patients with HIV infection.
Not available
S-EPMC2869083 | biostudies-literature
Sort   by:  
 Page size